1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Latent TB Detection Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Latent TB Detection Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Government Initiatives to Promote Tuberculosis Detection
5.2 Market Opportunities
- 5.2.1 Advancements in Tuberculosis Diagnosis
5.3 Future Trends
- 5.3.1 Outsourcing Locations for Tuberculosis Diagnosis
5.4 Impact of Drivers and Restraints
6. North America Latent TB Detection Market Regional Analysis
6.1 North America Latent TB Detection Market Overview
6.2 North America Latent TB Detection Market Revenue 2018-2027 (US$ Million)
6.3 North America Latent TB Detection Market Forecast Analysis
7. North America Latent TB Detection Market Analysis – by Test
7.1 Tuberculin Skin Test
- 7.1.1 Overview
- 7.1.2 Tuberculin Skin Test: North America Latent TB Detection Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Interferon Gamma Released Assay
- 7.2.1 Overview
- 7.2.2 Interferon Gamma Released Assay: North America Latent TB Detection Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Latent TB Detection Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Diagnostic Centers
- 8.2.1 Overview
- 8.2.2 Diagnostic Centers: North America Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Laboratories
- 8.3.1 Overview
- 8.3.2 Laboratories: North America Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Latent TB Detection Market – North America Analysis
9.1 North America
- 9.1.1 North America Latent TB Detection Market Breakdown, by Key
Country, 2021 and 2027 (%)
- 9.1.1.1 North America Latent TB Detection Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 US: North America Latent TB Detection Market Breakdown, by Test
- 9.1.1.1.2 US: North America Latent TB Detection Market Breakdown, by End User
- 9.1.1.2 Canada:
North America Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Canada: North America Latent TB Detection Market Breakdown, by Test
- 9.1.1.2.2 Canada: North America Latent TB Detection Market Breakdown, by End User
- 9.1.1.3 Mexico :
North America Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 Mexico : North America Latent TB Detection Market Breakdown, by Test
- 9.1.1.3.2 Mexico : North America Latent TB Detection Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Latent TB Detection Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 ARKRAY, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 BD
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 bioMerieux SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 F. HOFFMANN-LA ROCHE LTD.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Lionex GmbH
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Oxford Immunotec Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 QIAGEN
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Serum Institute of India Pvt. Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Latent TB Detection Market
